These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

61 related articles for article (PubMed ID: 6413445)

  • 1. Inhibition of lymphocyte transformation by a factor from Pseudomonas aeruginosa.
    Patt LM; Barrantes DM; Taylor-Norton J; Houck JC
    Int J Tissue React; 1983; 5(2):135-40. PubMed ID: 6413445
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Purification of a product from Salmonella typhimurium with the ability to inhibit mitogen-induced proliferation of murine splenic T-lymphocytes.
    Matsui K
    FEMS Immunol Med Microbiol; 1996 Feb; 13(2):155-60. PubMed ID: 8731024
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Inhibition of proliferation of a murine myeloma cell line and mitogen-stimulated B lymphocytes by the antibiotic amphotericin B (Fungizone).
    Walls EV; Kay JE
    Immunology; 1982 Sep; 47(1):115-21. PubMed ID: 6981585
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Molecular and biological characterization of anticarcinogenic and tumor cell growth-inhibitory activities of Syrian hamster lymphotoxin.
    Ransom JH; Evans CH
    Cancer Res; 1983 Nov; 43(11):5222-7. PubMed ID: 6604574
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effects of gypenosides on mouse splenic lymphocyte transformation and DNA polymerase II activity in vitro.
    Liao DF; Lu N; Lei LS; Yu L; Chen JX
    Zhongguo Yao Li Xue Bao; 1995 Jul; 16(4):322-4. PubMed ID: 7668101
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Blast transformation of mouse splenic B-lymphocytes with extracts of Mycoplasma hyorhinis.
    Butler GH; Göbel U; Stanbridge EJ
    Isr J Med Sci; 1984 Sep; 20(9):891-4. PubMed ID: 6334671
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Partial purification and characterization of a BCGFII from EL4 culture supernatants.
    Dutton RW; Wetzel GD; Swain SL
    J Immunol; 1984 May; 132(5):2451-6. PubMed ID: 6609198
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Effects of Phytolacca acinosa polysaccharide on splenic lymphocyte proliferation and cytokine secretion from splenic lymphocyte and macrophage].
    Wang HB; Zheng QY; Ju DW; Fang J
    Yao Xue Xue Bao; 1993; 28(10):732-7. PubMed ID: 8009984
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Opposing effects of the polycation hexadimethrine (polybrene) on normal and leukemic lymphocytes.
    Patt LM; Houck JC
    Pharmacology; 1985; 30(2):109-14. PubMed ID: 3156385
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Endotoxin-induced T lymphocyte proliferation.
    Vogel SN; Hilfiker ML; Caulfield MJ
    J Immunol; 1983 Apr; 130(4):1774-9. PubMed ID: 6601137
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Biological specificity of low molecular weight inhibitors of lymphocyte transformation.
    Patt LM; Barrantes DM; Houck JC
    Pharmacology; 1982; 24(2):74-81. PubMed ID: 6210916
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Recombinant human macrophage-colony stimulating factor suppresses the mouse mixed lymphocyte reaction.
    Sakurai T; Yamada M; Simamura S; Motoyoshi K
    Cell Immunol; 1996 Jul; 171(1):87-94. PubMed ID: 8660842
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Constitutive production by the WEHI-3 cell line of B cell growth and differentiation factor that co-purifies with interleukin 1.
    Booth RJ; Prestidge RL; Watson JD
    J Immunol; 1983 Sep; 131(3):1289-93. PubMed ID: 6604093
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Recombinant Pseudomonas exoenzyme S and exoenzyme S from Pseudomonas aeruginosa DG1 share the ability to stimulate T lymphocyte proliferation.
    Bruno TF; Woods DE; Storey DG; Mody CH
    Can J Microbiol; 1999 Jul; 45(7):607-11. PubMed ID: 10497789
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Thymus-derived inhibitor of lymphocyte proliferation. II. Tissue specificity in vitro and in vivo.
    Rijke EO; Lempers HC; Ballieux RE
    Cell Tissue Kinet; 1981 Jan; 14(1):31-8. PubMed ID: 6451295
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Soluble factors for B cell activation: a T cell hybridoma that secretes a specific B cell growth factor.
    Garchon HJ; Levi-Strauss M; Carnaud C; Bach JF
    J Immunol; 1983 Feb; 130(2):777-80. PubMed ID: 6600254
    [TBL] [Abstract][Full Text] [Related]  

  • 17. In vitro inhibition of lymphocyte proliferation by Pseudomonas aeruginosa phenazine pigments.
    Sorensen RU; Klinger JD; Cash HA; Chase PA; Dearborn DG
    Infect Immun; 1983 Jul; 41(1):321-30. PubMed ID: 6408002
    [TBL] [Abstract][Full Text] [Related]  

  • 18. An extract of Uncaria tomentosa inhibiting cell division and NF-kappa B activity without inducing cell death.
    Akesson C; Lindgren H; Pero RW; Leanderson T; Ivars F
    Int Immunopharmacol; 2003 Dec; 3(13-14):1889-900. PubMed ID: 14636838
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Inhibition of leukemic cell proliferation by one or more factors released from splenic BCL1 cells.
    Bessler H; Hart J; Slavin S; Djaldetti M
    Exp Hematol; 1995 Dec; 23(13):1353-7. PubMed ID: 7498363
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Early signals in alloantigen induced B-cell proliferation. Comparison between B-cell triggering by intact allogeneic cells and solubilized alloantigen.
    Genaro AM; Boscá L
    J Immunol; 1993 Aug; 151(4):1832-43. PubMed ID: 8345185
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.